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Abstract 
Study Design: Systematic review 
Objective: The aim of the current study was to assess the effect of catastrophizing on 
treatment efficacy and outcome in patients treated for low back pain. 
Summary of Background Data: Psychological factors including catastrophizing thoughts are 
believed to increase the risk for chronic low back pain. The influence of catastrophizing is 
debated. 
Methods: In September 2012 the following databases were searched: BIOSIS, CINAHL, 
Cochrane Library, Embase, OTSeeker, PeDRO, PsycInfo, Medline, Scopus, and Web of 
Science. For 50 of 706 references full text was assessed. Results based on 11 studies were 
included in this analysis. 
Results: In 11 studies, a total of 2,269 patients were included. Seven studies were of good and 
four of moderate methodological quality. Heterogeneity in study settings, treatments, 
outcomes, and patient populations impeded meta-analysis. Catastrophizing at baseline was 
predictive for disability at follow-up in four studies and for pain in two studies. Three studies 
found no predictive effect of catastrophizing. A mediating effect was found in all studies 
(n=5) assessing the impact of a decrease in catastrophizing during treatment. A greater 
decrease was associated with better outcome. Most studies that investigated the moderating 
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effects on treatment efficacy found no effect (n= 5). However, most studies did not look for a 
direct interaction between the treatment and catastrophizing thoughts. No study investigated 
the influence of catastrophizing on work-related outcomes including return to work. 
Conclusion: Catastrophizing predicted degree of pain and disability and mediated treatment 
efficacy in most studies. The presence of catastrophizing should be considered in patients 
with persisting back pain. Limited evidence was found for the moderating effects on treatment 
efficacy. Future research should aim to clarify the role of catastrophizing as a moderator of 
outcome and investigate its importance for work-related outcomes.  
 
Key words: low back pain; back pain; catastrophizing; fear avoidance; fear avoidance beliefs; 
fear avoidance model; prognosis; outcome; treatment outcome; mediator; 
moderator; predictor 
 
Level of Evidence: 1 
Mini Abstract 
The literature about the effect of catastrophizing on treatment efficacy and outcome in 
patients treated for low back pain was systematically assessed. In 11 studies catastrophizing 
predicted degree of pain and disability and mediated treatment efficacy. Limited evidence was 
found for the moderating effects on treatment efficacy. 
Key Points 
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This is a systematic review summarizing the effect of catastrophizing on treatment efficacy 
and outcome in patients treated for low back pain. 
In 11 studies catastrophizing predicted degree of pain and disability and mediated treatment 
efficacy. 
Limited evidence was found for the moderating effects on treatment efficacy. 
The presence of catastrophizing should be considered in patients with persisting back pain. 
 
Introduction 
Patients’ attitudes and coping mechanisms have been shown to play a causal role in the 
chronification of low back pain (LBP). Almost all adults once in their lifetime complain about 
LBP, but only 10-15 percent develop chronic LBP.
1
 This small percentage of patients 
accounts for three-quarters of the costs of medical care and lost productivity associated with 
LBP.
2,3
 There is consensus among experts to avoid unnecessary investigation and 
overtreatment of patients with acute LBP by treating symptomatically with encouragement to 
return to normal activity.
4
 Persisting pain for several weeks strongly predicts the development 
of chronic low back pain, a condition where complete recovery and return to full physical 
function are often difficult to achieve.
5
 Current research aims to identify risk indicators for 
delayed recovery in patients with sub-acute LBP in order to optimize treatment and avoid 
chronification. Targeted and timely interventions in patients at risk for chronic pain facilitate 
recovery and may reduce health care costs.
6
 
The Fear Avoidance Model (FAM) is a theoretical model that describes how psychological 
factors affect the experience of pain and the development of chronic pain and disability.
7
 
Within this theoretical model, the presence of catastrophizing thoughts or behavior is a 
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prerequisite for poor outcome and is defined as “an exaggerated negative mental set brought 
to bear during actual or anticipated painful experience.”8  It is theorized that negative beliefs 
about pain and/or negative illness information leads to a catastrophizing response in which 
patients imagine the worst possible outcome. This leads to fear of activity and avoidance that 
in turn causes disuse and resultant distress, reinforcing the original negative appraisal in a 
deleterious cycle.
7
 In chronic cases, catastrophizing may become a cognitive coping strategy 
based on the patient’s characteristic coping style or because catastrophizing is believed to 
have prevented severe pain or other aversive outcomes in the past.
9
 The FAM suggests that 
patients without catastrophizing and fear avoidance beliefs (FAB) are more likely to confront 
pain problems and are more active in the coping process. This type of “good” coping has been 
used to develop interventions for those high in catastrophizing and FAB. 
Although there is some empirical support for the FAM, it is a matter of debate as to how 
and when to best assess catastrophizing in clinical practice. Current treatment guidelines for 
LBP recommend the timely identification and initiation of multidisciplinary treatment for 
other psychological factors (e.g. depression, distress, job dissatisfaction) associated with 
increased risk for delayed recovery.
10-12
 Whether catastrophizing influences treatment 
outcome in patients with low back pain remains unclear. 
To date, the role of catastrophizing on treatment efficacy in LBP has not been reviewed 
systematically. The aim of this review is to assess the influence of catastrophizing on 
treatment response in randomized controlled trials (RCTs) in patients with LBP. 
 
Materials and methods 
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This systematic review follows the recommendation of the PRISMA statement (Figure 1) on 
conducting systematic reviews of RCTs.
13
 
 
Literature Search 
We identified all RCTs meeting our eligibility criteria published between January 1980 and 
September 2012. The following databases were search by an experienced librarian (XX): 
BIOSIS, CINAHL, Cochrane Library, Embase, OTSeeker, PeDRO, PsycInfo, Medline, 
Scopus, and Web of Science. Search terms for catastrophizing were identified in the literature 
(e.g. catastrophising, catastrophization, catastrophisation). Two detailed search strategies are 
depicted in Appendix 1. To ensure the completeness of the literature search, one reviewer 
(XX) conducted an electronic hand search of the six most often retrieved journals and added 
all potentially eligible references not retrieved by the systematic search. In addition, 
bibliographies of included studies relevant to the research question were searched and 
potential eligible references included in the full text review (inclusion and exclusion criteria 
applied). 
 
Eligibility Criteria 
All RCTs were considered eligible that met the following criteria: they reported results 
concerning patients seeking care for LBP, they assessed the influence of catastrophizing on 
treatment outcome, and they were published between January 1980 and September 2012. We 
focused on RCTs with at least 30 patients per group because of a concern about sample size. 
Assuming a reduction in perceived disability that was one-third greater in the treatment group 
when compared to the reference group, a sample size of 37 patients per group would be 
sufficient to detect the difference in allowing a drop-out rate of 15% (alpha 0.80, significance 
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level 0.05). No limits for the study setting or language of the publication were applied. 
Excluded were reports from conference proceedings.  
 
Study Selection, Data Extraction and Synthesis 
The bibliographic details of all retrieved articles were stored. Two reviewers (XX and XX) 
independently screened all references by title and abstract and reviewed full texts in all 
studies that met the pre-defined eligibility criteria. Disagreements were discussed and 
resolved by consensus or by third-party arbitration (XX). Alternative researchers with specific 
language proficiencies were approached for non-English language references.  
 
Outcome Definition  
All investigated outcomes were extracted and categorized into work-related (e.g. sick days, 
employment) and non-work-related outcomes (e.g. pain, perceived disability). Each method 
of outcome measurement was appraised with regards to their validity and reliability and was 
operationalized [e.g. perceived disability measured by Oswestry Disability Index (ODI)]. 
 
Quality Assessment 
The internal validity of each study was assessed using the Scottish Intercollegiate Guidelines 
Network (SIGN) Methodology checklist for RCTs by the two reviewers independently (XX 
and XX).
14
 Quality was rated as follows: High (++): most of the criteria have been fulfilled. 
If not fulfilled, the conclusions of the study are very unlikely to alter. Moderate (+): some 
criteria fulfilled. Criteria not adequately described are unlikely to alter the conclusions. Low (-
): few or no criteria fulfilled. The conclusions are likely to alter. 
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As recommended by SIGN, studies rated by both reviewers as low quality were excluded 
from further analysis. 
 
Operationalization of Catastrophizing as Predictor, Mediator, and Moderator 
The definitions for predictor, mediator, and moderator were adopted from Pincus and 
colleagues:
15
  
 Predictor: baseline catastrophizing affects outcome but does not interact with the 
allocated treatment intervention.  
 Mediator: change in catastrophizing during treatment impacts outcome, with or 
without interacting with allocated treatment.  
 Moderator: catastrophizing at baseline interacts with treatment.  
The quality of the moderator analysis was assessed for each study by two reviewers (XX 
and XX) and discussed with an experienced statistician (XX). The following factors were 
considered: 1) Was the analysis a priori defined; 2) Was the selection of factors for the 
analysis clinically plausible; 3) Were moderators measured prior to randomisation; and 4) 
Was there an adequate quality of measurement of baseline factors, that contains an explicit 
test of the interaction between moderator and treatment? 
Psychometric Properties and Description of the Questionnaires  
The Pain Catastrophizing Scale (PCS) consists of 13 questions.
16,17
 The score is a sum of all 
13 items (each item on a scale of 0 – 4, range 0 – 52). The higher the score, the more 
catastrophizing thoughts are present. The internal consistency is high (Cronbach’s alpha 0.87 
to 0.95).
17-19
 The three catastrophizing subscales are: rumination (sum of item 8, 9, 10, 11; 
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range 0 – 16), magnification (sum of items 6, 7, 13; range 0 – 12), and helplessness (sum of 
items 1, 2, 3, 4, 5, 12; range 0 – 24). The internal consistency is moderate to high (Cronbach’s 
alpha: rumination 0.87 – 0.95, magnification 0.66 – 0.88, helplessness 0.78 – 0.91).17,19 
The Coping Strategies Questionnaire (CSQ) consists of a 48-item checklist assessing six 
cognitive and two behavioral coping strategies.
9
 Six questions assess catastrophizing (item 5, 
12, 14, 28, 38, 42). The score is computed by summing responses to the six items (each item 
is scored 0 – 6 points, range 0 to 36). Internal consistency and reliability in a low back pain 
population was good in all sub-scales (Cronbach’s alpha between 0.71 and 0.85.9 The 
Cronbach’s alpha of the catastrophizing subscale was between 0.789 and 0.84.20 
The Pain-Related Self-Statements Scale (PRSS) is intended to assess situation-specific 
cognitions that either promote or hinder attempts to cope with pain.
21
 Catastrophizing is 
assessed with the items 2, 4, 7, 9, 10, 13, 15, 16 and has been shown to be reliable and valid 
(Cronbach’s alpha 0.83).21 Items are scored on a Likert scale (0 to 5 points); the score is the 
average of all items (range 0 to 5). Higher values indicate more catastrophizing.  
The Pain Cognition List (PCL) is a 50 item scale that measures a verbal-cognitive response 
system of chronic pain.
22
 Catastrophizing is measured by 17 items (each item scored on a 
five-point Likert scale; 1: highly disagree to 5: totally agree). A sum score is obtained per 
subscale for each patient. The catastrophizing subscale (range 17 – 85) has been shown to be 
reliable and valid (Cronbach’s alpha 0.88).22,23 
The Pain Coping and Cognition List (PCCL) is a 42-item self-report questionnaire, 
developed on the basis of the PCL, CSQ, and MPLC (Multidimensional Pain Locus of 
Control Questionnaire) covering attributions, expectancies, and cognitive coping strategies. 
Each item is scored on a six-point Likert scale (1: totally disagree to 6: totally agree). 
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Catastrophizing is covered by one of the four subscales (12 items). The internal consistencies 
of the Catastrophizing subscale proved to be good (Cronbach’s alpha 0.85).24,25 
The PCS and the CSQ are considered to be equally reliable and valid for the measurement 
of catastrophizing thoughts.
26,27
 It has therefore been proposed to use the PCS in research that 
aims to explore catastrophizing.
26
 The PRSS is considered to be more pain-specific when 
compared to the CSQ. A direct comparison of the PRSS and the CSQ showed a moderately 
strong linear relationship between the two scales (r=0.56).
21
 The correlation between the 
catastrophizing subscale of the PCL and the CSQ or PCS was high (r=0.70).
23
 
 
Statistical analysis 
Due to heterogeneous study populations, measurements, and scales used as well as outcomes 
investigated, only descriptive statistics were used to summarize findings across all cohort 
studies. Forest plots were generated based on values reported using R statistical software for 
Windows.
28
 
 
Results 
Study Selection 
The search and inclusion process is summarized in Figure 1. Out of 1,473 records, 50 were 
reviewed in full text. The full text assessment utilizing the inclusion and exclusion criteria 
resulted in the exclusion of 37 studies.The main reasons for exclusion were are summarised in 
Figure 1. In total, 13 publications based on 11 RCTs were included in the analysis. 
 
Study Characteristics 
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RCTs conducted in a general practitioner setting (GP, n=3), in rehabilitation clinics (n=3), 
hospitals / specialists (n=3), and physical therapy outpatient clinics (n=2) (baseline 
characteristics in Table 1). The study quality was good in seven and moderate in six studies 
(Appendix 2). The primary outcome in most RCTs was self-report measurements (i.e. pain, 
disability, change in pain or disability). No RCT investigated return to work or other work-
related outcomes. Five publications (four RCTs) used the CSQ for assessing catastrophizing, 
29-33
 three the PCS (two RCTs),
34-36
 two the PCL,
37,38
 two the PRSS catastrophizing 
subscale,
39,40
 and one the PCCL.
25
 Cut-off values were only applied once (median split >11, 
≤11).31 
 
The Influence of Catastrophizing on Treatment Efficacy and Outcome 
A summary of the predictor-, mediator-, and moderator-analyses is provided in Table 2. 
Catastrophizing at baseline predicted treatment outcome without interacting with the 
treatment in four RCTs,
29,34,36,38
 but was not predictive in two other RCTs.
33,37
 High 
catastrophizing was associated with more disability at follow-up in four RCTs 
29,34,36,38
 and 
with more pain in two RCTs.
36,38
 Only one RCT failed to find an association between high 
catastrophizing scores and disability.
33
 In this RCT, baseline catastrophizing was very low 
(mean CSQ 8.4 on a 0 to 36 point scale). Catastrophizing was not predictive for treatment 
satisfaction.
37
 
In all five RCTs that investigated the mediating effects of a change in catastrophizing from 
baseline to follow-up, a decrease in catastrophizing was found to be associated more daily 
activity,
29
 more internal pain control,
25
 a greater decrease in highest level of pain (not for 
average pain or disability) in one RCT,
32
 and more decrease in pain
35
 and disability in 
another
34
 (Table 3).  
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Catastrophizing moderated treatment efficacy in two publications based on one RCT
30,31
 
but not in five other RCTs.
29,34,37,39,40
 One RCT found high catastrophizing scores to reduce 
treatment efficacy for usual care (UC) but not in the minimal intervention study (MIS) 
targeted to reduce pain-related fear and activity avoidance.
30,31
 No moderating effect was 
found in three RCTs that compared exercise to cognitive behavioral approaches (CBT).
29,34,39
 
A detailed description of the study results is given in Appendix 3.  
 
Discussion 
Main Findings 
In this systematic review of 11 randomized controlled trials (RCTs) on the effect of 
catastrophizing in patients with low back pain, we found catastrophizing to predict outcome 
for pain and disability in four RCTs. The RCTs that investigated mediating effects showed an 
association between a decrease in catastrophizing and an increase in daily activities and a 
decrease in pain. There was limited and conflicting evidence for the moderating effect of 
catastrophizing on treatment efficacy. No RCT assessed work-related outcomes. 
The analysis of a moderator effect was inadequate in most RCTs and a final conclusion 
would be premature. All RCTs showing no moderating effect of catastrophizing included too 
few patients to detect a difference between the treatment arms. Therefore, any moderating 
effects could have been easily missed. Further, low catastrophizing at baseline could explain 
non-predictive findings. However, baseline values were not consistently associated with 
outcomes. Most RCTs did not look for a direct interaction test between the treatment and 
catastrophizing. 
 
Results in Light of Existing Literature 
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The effect of catastrophizing on the outcome of treatment has received increasing 
attention.
41,42
 To our knowledge this is the first systematic review that assessed the predictive, 
mediating, and moderating effect of catastrophizing in patients with low back pain. In surgical 
patients, catastrophizing has been associated with more post-surgical pain and poorer quality 
of life.
43
 The influence of catastrophizing on outcome in patients undergoing non-surgical 
treatments has not been reviewed systematically. In a recent analysis of subgroups that might 
benefit from self-management programs in musculoskeletal pain, catastrophizing was 
identified as a moderator in one study.
44
 The current analysis further expands the knowledge 
about the influence of catastrophizing in patients with low back pain on treatment efficacy 
and outcome. While there was a consistent association between higher catastrophizing and 
more disability and pain at follow-up, there is insufficient data available to analyze the 
influence of catastrophizing on work-related outcomes including return to work and sick days. 
Pain catastrophizing conceptually belongs to the fear avoidance model. It is believed that 
catastrophizing is a precursor of pain-related fear.
45
 Fear avoidance beliefs decrease the 
treatment efficacy of treatments based on biomedical concepts (e.g. physical therapy) and 
increase treatment efficacy in treatments that aim to reduce fear avoidance beliefs (XX 
submitted). However, it is possible to have fear avoidance beliefs without catastrophizing.
46
 
To date it is not known if one can also have high catastrophizing and low fear avoidance 
beliefs.  
 
Limitations 
The main limitation is small sample sizes in most RCTs. None of the RCTs provided a power 
analysis for moderator effect and most RCTs did not conduct a direct test for any interaction 
between catastrophizing and treatment. The heterogeneity of studies and the methodological 
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limitations impeded the authors from conducting a meta-analysis. We have tried to balance 
these limitations by providing a comprehensive comparative description of all the RCTs 
included. 
 
Implications for Research 
Future research should aim at identifying the importance of catastrophizing in relation to fear 
avoidance beliefs and other psychological factors. Further, the influence of catastrophizing on 
treatment response in currently used treatment strategies in low back pain should be 
investigated. The current analysis suggests that any catastrophizing can be associated with 
worse outcome. It is unknown whether or not cut-off values can be applied to detect patients 
at high risk.  
 
Implications for Practice 
The findings of this review suggest that high catastrophizing scores are associated with more 
pain and disability at follow-up. It has been shown that catastrophizing may be modified with 
treatment and that a decrease during treatment is associated with better outcome.
25,38,47
 
Therefore measures that assess catastrophizing might be helpful in clinical practice to identify 
patients at risk for delayed recovery. Questionnaires used in the analysed RCTs consisted of at 
least six items. In a busy back pain patient clinic shorter screening tools are warranted. 
Stratified primary care management by using screening tools that incorporate catastrophizing 
among other psychological domain, e.g. the STarT Back Tool or the Orebro Questionnaire
48
 
has been shown to be effective and reduce costs.
6,49
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Conclusion 
Catastrophizing thoughts were associated with more pain and disability at follow-up in 
patients with low back pain. A decrease in catastrophizing during treatment is associated with 
better outcome. Insufficient evidence was available for the assessment of moderating effects 
and no RCT investigated work-related outcomes. 
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Figure 1: Exclusion criteria. 
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Table 1: Baseline characteristics of studies investigating Low Back Pain 
Less than six months 
Study Setting Diagnostic 
criteria 
DD: days 
mean (SD) 
Age mean 
(SD) 
Treatment n (f) FU 
Jellema, 
Vlaeyen, 
2006 
18
 
Randomization on 
level GP practice. 
Participating GPs 
selected 10 
consecutive 
patients, 
Netherlands 
NSLBP, 14.6 % 
radiating below 
the knee 
UC median 
14 IQR (7-
21) 
MIC 11 (5-
21) 
UC 42.0 
(12); 
MIC 43.4 
(11.1) 
UC (n= 171) 
vs. 
MIC (n= 143) 
314 
(149) 
6 weeks 
Jellema, 
2005 
19
 
Same study as 
Jellema, Vlaeyen, 
2006 
     52 
weeks 
Hancock, 
Davies, 
2009 
10
 
Patient presenting 
in 40 general 
practitioners 
working in primary 
practice across 
Sydney, Australia 
NSLBP: 12. rib to 
buttock crease 
with moderate 
pain and 
moderate 
disability (SF-36, 
item 7/8) 
9.13 (9.31) 40.7 
(15.6) 
Spinal manipulation 
+ Diclofenac / 
Placebo (n= 119) vs. 
Placebo Spinal 
manipulation + 
Diclofenac / Placebo 
(n= 120) 
239 
(105) 
Time to 
recovery 
Smeets, 
2009 
40
 
Recruitment by 
clinician referral, 
advertisement, 
waiting list PT 
clinics, treatment in 
7 physiotherapy 
clinics in Australia 
and New Zealand 
NSLBP ≥6 weeks 
but ≤12 weeks 
42-56 
(48%), 63-
77 (37%), 
>84 (15%) 
49.9 
(15.8) 
EA (n= 63) vs 
SEA (n= 63) vs 
ESA (n= 65) vs 
SESA (n= 68) 
259 
(124) 
1 year 
George, 
Zeppieri, 
2008 
9
 
Patients referred for 
rehabilitation to 
three participating 
University of 
Florida affiliated 
clinics, U.S.A. 
NSLBP + SLBP 
Quebec Task 
Force on Spinal 
Disorders 
(QTFSD). Leg 
pain TBC 38%, 
GA 49%, GX 
42% 
TBC 47 
(34), TBC + 
GA 41 (39), 
TBC + GX 
69 (49) 
37.5 
(14.9) 
Treatment-based 
classification (TBC) 
physical therapy vs. 
TBC + graded 
activity (GA) vs. 
TBC + graded 
exposure (GX) 
108 
(74) 
1 and 6 
months 
Beneciuk, 
2012 
3
 
Same study as 
George, Zeppieri 
2008 
      
Hill, 
2008 
13
 
Patient recruited 
from 28 general 
practices, treated by 
trial physio-
therapists, North 
Staffordshire, UK 
NSLBP ≤12 
weeks for the first 
or second time 
≤12 weeks 40.65 
(11.8) 
Pain management 
program or PT + 
manipulation 
402 
(210) 
1 year 
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Wessels, 
2007 
53
 
Patients recruited 
from several 
hospitals, treatment 
setting n.r., 
Germany 
NSLBP. At least 
1 LBP episode in 
the last 2 years 
n.r. 40 (11.1) Multidisciplinary 
program (n= 80) vs. 
exercise program 
(n= 82) 
162 
(150) 
Posttreat
ment 
(13 
weeks) 
More than 6 months 
Study Setting Diagnostic 
criteria 
DD Age mean 
(SD) 
Treatment n (f) FU 
Leeuw, 
2008 
24
 
Patients recruited 
via 9 various 
outpatient facilities 
or newspaper-ad, 
treated in 4 
outpatient 
rehabilitation 
centers, 
Netherlands 
NSLBP ≥3 
months, RDQ >3, 
TSK >33 
9.0 years 
(9.4) 
45.3 
(9.45) 
Exposure in vivo (n= 
42) 
vs 
GA (n= 43) 
85 
(41) 
6 
months 
Oosterhof, 
2008 
30
 
Patients referred 
by family doctor or 
medical specialist 
to the Pain Centre 
of Radboud 
University Medical 
Centre Nijmegen, 
Netherlands 
NSLBP ≥6 months 6.4 years 
(0.6) 
50.2 
(1.1) 
TENS (n= 81) 
vs 
sham TENS (n= 82) 
165 
(97) 
10 days 
Smeets, 
2006 
41
 
Patients referred 
by GPs and 
medical specialists 
to 3 Dutch 
outpatient 
rehabilitation 
centers 
NSLBP ≥3 
months, ability to 
walk at least 100m 
without 
interruption 
4.8 years 
(6.1) 
41.81 
(9.92) 
APT (n= 52) vs 
CBT (n= 55) vs 
CT (n= 55) vs 
WL (n= 49) 
227 
(105) 
70 days 
Mannion, 
1999 
27
 
Hospital based 
outpatient 
treatment (PT), 
recruitment by 
advertisement, 
Switzerland 
NSLBP ± referred 
pain (non-
radicular), 
continual or 
recurrent, ≥3 
months, causing 
absence from work 
or solicitation of 
medical attention 
10.9 years 
(9.4) 
45.1 
(10.0) 
Modern active PT 
(n= 49) vs. muscle 
conditioning on 
training devices (n= 
49) vs. low-impact 
aerobics (n= 50) 
148 
(84) 
6 
months 
Spin-
hoven, 
2004 
42
 
Patients referred 
by GPs and 
medical specialists 
to Hoensbroeck 
Rehabilitation 
Center, 
Netherlands 
NSLBP ≥6 months 10.1 months 
(8.7) 
40.0 (9.2) OPCO (n= 59) vs 
OPDI (n= 58) vs 
WLC (n= 31) 
159 
(94) 
1 year 
 
LBP: low back pain; NSLBP, non-specific low back pain; SLBP, specific low back pain; PF, prognostic factor 
reporting of the total of 16 possible domains; SIGN, SIGN quality rating: ++ high quality, + moderate quality; 
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DD, Disease Duration; FU, Follow-up; TBC, treatment-based classification; GA: graded activity; GX, graded 
exposure; PT, physical therapy; UC, usual care; MIS, minimal intervention strategy; AM, active management; 
CBT, cognitive behavioral therapy; APT, active physical therapy; CT, combined therapy; WL, waiting list; 
GivE, Graded in vivo exposure; QA, Questionnaire used; FAB, Fear Avoidance Beliefs; FABQ, fear avoidance 
questionnaire; FABQ-P, FABQ physical activity sub-scale; FABQ-W: FABQ work sub-scale; TSK: Tampa 
Scale of Kinesiophobia; OR, odds ratio; MA, multiple regression analysis; IQR: interquartile range; CMID, 
clinical meaningful important difference; Log. Reg., logistic regression; U.L., univariante logistic regression; 
L.R., linear regression; ODI, Oswestry Disability Index: higher score indicates more disability: CMID = ≥12 
points reduction; RTW, return to work; CPG, chronic pain grade (von Korff) questionnaire: higher score 
indicates more pain; GCP, graded chronic pain scale; PDI, pain disability index (Pollard, 1984): higher score 
indicates more disability; RMQ, Roland Morris Questionnaire: higher score indicates more disability: CMID = 
≥2-3 point reduction, ≥30% change; SF-36D, physical health sub-score: higher score indicates higher level of 
functioning; SF-36M, mental health sub-score: higher score indicates higher level of functioning; EA, exercise + 
advice; SEA, sham exercise + advice; ESA, exercise + sham advice; SESA, sham exercise + sham advice; 
OPCO, operant behavioral treatment and cognitive coping skills training; OPDI, operant behavioral treatment 
and group discussion; WLC, waiting-list control condition 
 
 
Table 2: Summary of the effect of catastrophizing as predictor, mediator and moderator 
Less than six months 
Study 
Year 
Scale: 
mean 
(SD) 
Predictor Mediator Moderator 
Jellema, 
Vlaeyen, 
2006 
18
 
CSQ 
11.8 
(6.7) 
Ø Ø  
Moderator in UC 
(OR 0.94, 95% 
CI, 0.89 – 0.99) 
– 
No moderator in 
MIS (OR n.r.) 
Jellema, 
2005 
19
 
CSQ 
11.8 
(6.7) 
Ø Ø  
High catastrophizing (>11) in MIS 
more recovery than in UC 
(OR 0.72, 95% CI, 0.29 – 1.80) 
Low catastrophizing (≤11) in MIS 
less recovery than in UC 
(OR 1.84, 95% CI, 0.80 – 4.22) 
Hancock, 
Davies, 
2009 
10
 
PRSS 
1.85 
(scale 
0-5) 
Ø Ø – 
No interaction of catastrophizing 
with treatment (NSAID vs. placebo) 
on pain and recovery 
Smeets, 
2009 
40
 
PRSS 
18 (9) 
Ø Ø – 
No significant influence of 
catastrophizing on exercise or advice 
for pain and disability  
George, 
Zeppieri, 
2008 
9
 
PCS 
range 
12.6 - 
20.7 
Ø  
Decrease in catastrophizing 
associated with more pain 
decrease 
(β 0.38, 95% CI, 0.09 – 0.67) 
Ø 
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Beneciuk, 
2012 
3
 
PCS 
16.3 
(11.2) 
 
High catastrophizing with 
high fear avoidance beliefs 
associated with more pain 
and disability in all treatment 
groups  
(p<0.05) 
Ø Ø 
Hill, 
2008 
13
 
CSQ 
8.4 
(6.7) 
– 
Catastrophizing not 
associated with disability 
after .12 months  
(univariante OR 1.77, 95% 
CI, 1.13 – 2.75; multivariante 
n.r.) 
Ø Ø 
Wessels, 
2007 
53
 
Ø  
Catastrophizing interferes 
with daily activity at 3 
months 
(β 0.25, 95% CI, 0.12 – 0.35) 
 
Decrease in catastrophizing 
explains 2.5% of total 
variability in outcome (MPI-
D) (β 0.236, 95% CI, 0.12 – 
0.35) 
– 
No significant interaction between 
catastrophizing and treatment 
(p = 0.06) 
More than 6 months 
Study 
Year 
Scale: 
mean 
(SD) 
Predictor Mediator Moderator 
Leeuw, 
2008 
24
 
PCS 
22.9 
(10.4) 
 
More catastrophizing is 
associated with more 
disability at 6 months 
(QPDBS β 0.43, 95% CI, 
0.25 – 0.61; PSC β 0.70, 95% 
CI, 0.41 – 0.99) 
 
Decrease in catastrophizing 
significantly mediated the 
effect of EXP relative to GA 
on disability and main 
complaint. Results n.r. 
– 
No significant interaction between 
catastrophizing and treatment 
(criteria for inclusion p <0.10) 
Oosterhof, 
2008 
30
 
PCL 
43.9 
(SE 
1.2) 
– 
Catastrophizing no influence 
on treatment satisfaction after 
10 days 
Ø – 
Catastrophizing no influence on 
treatment satisfaction (values n.r.) 
Smeets, 
2006 
41
 
PCL 
39 (12) 
 
Catastrophizing associated 
with more pain and disability 
in all treatment groups (APT, 
CBT and CT) after 2 months 
Ø Ø 
Mannion, 
1999 
27
 
Ø Ø  
Decrease in catastrophizing 
explains 23% decrease in 
greatest pain but not decrease 
in average pain and disability 
Ø 
Spinhoven, 
2004 
42
 
PCCL 
40.5 
(9) 
Ø  
Decrease in catastrophizing 
increases internal pain 
control 
(β 0.20, p < 0.05) 
Ø 
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Scale ranges: PCS 0 - 52, CSQ 0 - 36, PRSS 0 - 45, PCL 17 - 85, PCCL 12 – 72; Ø, not investigated; UC, usual 
care; MIS, minimal intervention strategy; CBT, cognitive behavioral therapy; APT, active physical therapy; CT, 
combined therapy; FAB, Fear Avoidance Beliefs; MPI-D, German version of the West Haven Multidimensional 
Pain Inventory 
 
Table 3: Moderating effect of catastrophizing on treatments 
Study 
Year 
Moderating effect on Treatment Test of 
interaction 
Disease 
Duration 
n FU 
(weeks) 
Outcome 
Jellema, 
2006 
18
 + 
2005 
19
 
Catastrophizing reduces treatment effect 
in Group 1: UC: guideline GP based 
care; but not in Group 2 MIS: GP 
provided information and advice for self-
care + Back Book 
no acute - 
subacute 
314 52 Non-work related: 
RMQ 
Hancock, 
Davies, 
2009 
10
 
No effect on NSAID vs. Placebo 
Group 1: Placebo + placebo 
manipulation 
Group 2: Diclofenac + placebo 
manipulation 
Group 3. Placebo + spinal manipulation 
Group 4: Diclofenac + manipulation 
yes acute 240 12 Non-work related: 
Number of days to 
recovery  
Smeets, 
2009 
40
 
No effect on all treatment groups:  
Group 1: CBT informed progressive 
exercise and PT advice stay active and 
addressing helpful beliefs 
Group 2: CBT informed exercise + sham 
advice 
Group 3: Sham exercise + advice 
Group 4: Sham exercise + sham advice 
no subacute 259 52 Non-work related: 
∆ pain (NRS) 
+ 
∆ disability (PSFS) 
Wessels, 
2007 
53
 
No interaction between catastrophizing 
and treatment: 
Group 1: Exercise 
Group 2: multidisciplinary prevention 
program including CBT, work 
hardening, back school 
no subacute - 
chronic 
162 13 Non-work related: 
MPI-D 
Leeuw, 
2008 
24
 
No interaction between catastrophizing 
and treatment: 
Group 1: operant behavioral GA: 
functional treatment goals, 2 
psychological sessions 
Group 2: EXP: CBT techniques by using 
PHODA to identify fear hierarchy 
yes chronic 85 26 Non-work related: 
QBPDS 
PSC 
Ooster-
hof, 
2008 
30
 
No influence on Group 1 TENS, and 
Group 2: Sham TENS 
yes chronic 165 10 Non-work related: 
treatment satisfaction 
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TENS, transcutaneous electrical nerve stimulation; UC, usual care; MIS, minimal intervention strategy; CBT, 
cognitive behavioral therapy; APT, active physical therapy; CT, combined therapy; PT, physical treatment; 
PHODA, Photograph Series of Daily Activities; FAB, Fear Avoidance Beliefs; MPI-D, German version of the 
West Haven Multidimensional Pain Inventory; RMQ, Roland and Morris Disability Questionnaire; QBPDS, 
Quebec Back Pain Disability Scale; PSC, Patient Specific Complaints; NRS, Numeric Rating Scale; PSFS, 
Patient-Specific Functional Scale 
 
Appendix 1: Search History for PubMed, CINAHL, PsychINFO October Week 2 2012 
Ovid MEDLINE(R), Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid 
MEDLINE(R) Daily and Ovid OLDMEDLINE(R) 1946 to Present 
 
# Query Results 
1 exp Low Back Pain/ 12474 
2 ((low or lower) adj3 ("back pain" or "back pains" or "back ache" or "back 
aches" or backache*)).ti,ab. 
16245 
3 ((lowback or lumbal or lumbar or lumbosacral) adj3 (pain* or ache* or 
syndrome)).ti,ab. 
3488 
4 (lumbago or lumbalgia or lumbalgesia or (lumbosacroiliac adj3 
strain)).ti,ab. 
1221 
5 or/1-4 23882 
6 exp Catastrophization/ 183 
7 (catastrophizing or catastrophising or catastrophization or 
catastrophisation).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, protocol supplementary concept, rare disease 
supplementary concept, unique identifier] 
1111 
8 (catastrophic adj3 (thinking or thought*)).ti,ab. 131 
9 (pain adj3 (catastrophizer* or catastrophiser*)).ti,ab. 20 
10 or/6-9 1185 
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11 5 and 10 179 
12 limit 11 to yr="1980 -Current" 179 
13 limit 12 to animals 0 
 
PsycINFO 1806 to October Week 2 2012 (Ovid) 
# Searches Results 
1 back pain/ and (low or lower).ti,ab. 1870 
2 ((low or lower) adj3 ("back pain" or "back pains" or "back ache" or "back 
aches" or backache*)).ti,ab. 
2206 
3 ((lowback or lumbal or lumbar or lumbosacral) adj3 (pain* or ache* or 
syndrome)).ti,ab. 
176 
4 (lumbago or lumbalgia or lumbalgesia or (lumbosacroiliac adj3 
strain)).ti,ab. 
26 
5 or/1-4 2534 
6 (catastrophizing or catastrophising or catastrophization or 
catastrophisation).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
1144 
7 (catastrophic adj3 (thinking or thought*)).ti,ab. 150 
8 (pain adj3 (catastrophizer* or catastrophiser*)).ti,ab. 25 
9 or/6-8 1222 
10 5 and 9 129 
11 limit 10 to yr="1980 -Current" 129 
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Appendix 2: Internal Validity of Studies (SIGN methodology checklist) 
11
 and assessment of moderators 
33
 
 
WC, well covered; AA, adequately addressed; PA, poorly addressed; NA, not addressed; NR, not reported; N/A, not applicable; Yes*, yes (not 
significant); No*, no (cluster) 
 
 
 
Study Year SIGN           Moderators 
  1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.9 1.10 2.1 3.1 A B C D E 
Wessels 2007 WC WC NR NR WC WC WC NA NA + - NF Yes No Yes No 
Jellema 2006 WC WC NA PA WC WC WC PA NA + G NF Yes No* Yes No 
Jellema 2005 WC WC NA PA WC WC WC PA NA + G NF Yes No* Yes No 
Leeuw 2008 WC WC WC AA WC WC WC WC NA + G+O NF Yes Yes Yes Yes 
Oosterhof 2008 WC WC WC WC WC WC AA WC NA ++ G NF Yes No Yes Yes 
Smeets 2009 WC WC WC WC WC WC AA WC NA ++ G Yes Yes Yes Yes No 
Smeets 2006 WC WC WC WC WC WC WC WC NA ++ O NF Yes Yes Yes No 
Mannion 1999 WC WC NA AA WC WC WC WC N/A ++ G+O NF Yes No Yes Yes* 
Spinhoven 2004 WC WC WC WC WC WC WC WC NA ++ H NF Yes No Yes Yes* 
Hill 2008 WC WC WC WC WC WC WC WC NA ++ N+O NF Yes Yes Yes No 
Hancock 2009 WC WC WC WC WC WC WC WC NA ++ H+G NF Yes Yes Yes Yes* 
George 2008 WC WC WC WC WC WC WC WC NA + - NF Yes Yes Yes No 
Beneciuk 2012 WC WC WC WC WC WC WC WC NA + - NF Yes Yes Yes No 
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quality: most of the criteria have been fulfilled. If not fulfilled, the conclusions of the study 
are very unlikely to alter; (+), moderate quality: some criteria fulfilled. Criteria not adequately 
described are unlikely to alter the conclusions; (-), low quality: few or no criteria fulfilled. 
The conclusions are likely to alter. 3.1 Funding: A, academic institution; H, healthcare 
industry; G, government; N, NGO; P, public funds; O, others; -, none 
Moderators 
A, a-priori analysis; B, selection of factors for analysis clinically plausible; C, moderators 
measured prior to randomisation; D, adequate quality of measurement of baseline factors; E, 
explicit test of the interaction between moderator and treatment 
Appendix 3: Results of all included studies 
Stu
dy 
Y
ea
r 
The
rap
y 
Foll
ow-
up 
(day
s) 
Outcom
e 
Que
stio
n-
nair
e 
Me
asu
re 
or 
cut-
off 
use
d 
MA
? 
Criteria 
for 
inclusio
n in MA 
Me
asu
re 
rep
orte
d 
val
ue 
CI 
(5) 
CI 
(95
) 
p 
Wes
sels 
20
07 
all 91 inteferen
ce with 
daily life 
West 
Haven 
Multidi
mension
al Pain 
Inventor
y 
German 
Version 
(MPI-D) 
d_C
SQ 
cat 
(0-
36) 
no yes first 
step: 
partial 
correlati
on 
coefficie
nts, 
p<0.2 
included 
sec step: 
regressi
on 
analysis 
with 
changes 
in 
interfere
nce 
Beta 0.2
05 
0.1
0 
0.3
1 
<0.
000
1 
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Wes
sels 
20
07 
all 91 inteferen
ce with 
daily life 
West 
Haven 
Multidi
mension
al Pain 
Inventor
y 
German 
Version 
(MPI-D) 
CS
Q 
cat 
(0-
36) 
no yes first 
step: 
partial 
correlati
on 
coefficie
nts, 
p<0.2 
included 
sec step: 
regressi
on 
analysis 
with 
changes 
in 
interfere
nce 
Beta 0.2
36 
0.1
2 
0.3
5 
<0.
000
1 
Wes
sels 
20
07 
cat 
x 
treat
men
t 
91 inteferen
ce with 
daily life 
West 
Haven 
Multidi
mension
al Pain 
Inventor
y 
German 
Version 
(MPI-D) 
CS
Q 
cat 
(0-
36) 
x 
treat
men
t 
no yes first 
step: 
partial 
correlati
on 
coefficie
nts, 
p<0.2 
included 
sec step: 
regressi
on 
analysis 
with 
changes 
in 
interfere
nce 
n.r. n.r. n.r. n.r. 0.0
6 
Jelle
ma 
20
06 
UC 364 ≥ 30% 
improve
ment in 
Roland 
and 
Morris 
Disabilit
y 
Questio
CS
Q 
cat 
(0-
36) 
no yes p<0.20 OR 0.9
4 
0.8
9 
0.9
9 
0.0
3 
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nnaire 
(RMQ) 
Jelle
ma 
20
06 
MIS 364 ≥ 30% 
improve
ment in 
Roland 
and 
Morris 
Disabilit
y 
Questio
nnaire 
(RMQ) 
CS
Q 
cat 
(0-
36) 
no no p<0.20 n.r. n.r. n.r. n.r. n.r. 
Jelle
ma 
20
05 
MIS 
vs 
UC 
364 no 
recovery 
(7 point 
Likert-
scale) 
CS
Q 
cat 
(0-
36) 
ms 
≤11 
yes  OR 1.8
4 
0.8
0 
4.2
2 
 
Jelle
ma 
20
05 
MIS 
vs 
UC 
364 no 
recovery 
(7 point 
Likert-
scale) 
CS
Q 
cat 
(0-
36) 
ms 
>11 
yes   OR 0.7
2 
0.2
9 
1.8
0 
  
Lee
uw 
20
08 
all 180 QBPDS 
(Quebec 
Back 
Pain 
Disabilit
y Scale) 
PCS 
(0-
52) 
no yes predefin
ed 
Beta 0.4
3 
0.2
5 
0.6
1 
<0.
001 
Lee
uw 
20
08 
all 180 PSC 
(Patient 
Specific 
Complai
nts) 
PCS 
(0-
52) 
no yes predefin
ed 
Beta 0.7 0.4
1 
0.9
9 
<0.
001 
Man
nion 
19
99 
all 180 ∆RMQ CS
Q 
cat 
(0-
no yes simple 
correlati
on 
n.r. n.r. n.r. n.r. n.r. 
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36) 
Man
nion 
19
99 
all 180 Δ in 
greatest 
pain 
(VAS) 
CS
Q 
cat 
(0-
36) 
no yes simple 
correlati
on 
n.r. n.r. n.r. n.r. n.r. 
Man
nion 
19
99 
all 180 Δ 
average 
pain 
(VAS) 
CS
Q 
cat 
(0-
36) 
no yes simple 
correlati
on 
n.r. n.r. n.r. n.r. n.r. 
Oost
er-
hof 
20
08 
all 10 proporti
on of 
patients 
satisfied 
with the 
initial 
treatmen
t results 
and 
willing 
to 
continue 
(yes or 
no) 
PCL 
cat 
(17-
85) 
no yes, 
mult
iple 
regr
essi
on 
mod
el 
r
2
 
increase
s at least 
0.01 for 
pain 
(VAS) 
n.r. n.r. n.r. n.r.   
Sme
ets 
20
09 
all 360 change 
in pain 
(11-
point 
scale) 
PRS
S 
cat 
(0-
45) 
1 
SD 
inc 
(9 
poin
ts) 
no clinical 
relevant 
effect 
modifica
tion (1 
SD 
change) 
Mea
n 
0.5
4 
0.3
5 
0.7
3 
<0.
001 
Sme
ets 
20
09 
ex 360 change 
in pain 
(11-
point 
scale) 
PRS
S 
cat 
(0-
45) 
1 
SD 
inc 
(9 
poin
ts) 
yes clinical 
relevant 
effect 
modifica
tion (1 
SD 
change) 
Mea
n 
-
0.0
7 
-
0.6
2 
0.4
8 
 
AC
CE
PT
ED
 
Sme
ets 
20
09 
adv 360 change 
in pain 
(11-
point 
scale) 
PRS
S 
cat 
(0-
45) 
1 
SD 
inc 
(9 
poin
ts) 
yes clinical 
relevant 
effect 
modifica
tion (1 
SD 
change) 
Mea
n 
-
0.2
4 
-
0.8
0 
0.3
1 
 
Sme
ets 
20
09 
all 360 change 
in 
patient-
specific 
function
al scale 
(0-10) 
PRS
S 
cat 
(0-
45) 
1 
SD 
inc 
(9 
poin
ts) 
no clinical 
relevant 
effect 
modifica
tion (1 
SD 
change) 
Mea
n 
-
0.3
1 
-
0.5
0 
-
0.1
2 
0.0
01 
Sme
ets 
20
09 
ex 360 change 
in 
patient-
specific 
function
al scale 
(0-10) 
PRS
S 
cat 
(0-
45) 
1 
SD 
inc 
(9 
poin
ts) 
yes clinical 
relevant 
effect 
modifica
tion (1 
SD 
change) 
Mea
n 
-
0.2
6 
-
0.7
9 
0.2
7 
 
Sme
ets 
20
09 
adv 360 change 
in 
patient-
specific 
function
al scale 
(0-10) 
PRS
S 
cat 
(0-
45) 
1 
SD 
inc 
(9 
poin
ts) 
yes clinical 
relevant 
effect 
modifica
tion (1 
SD 
change) 
Mea
n 
0.1
4 
-
0.4
0 
0.6
8 
  
Sme
ets 
20
06 
all 70 Roland 
and 
Morris 
Disabilit
y 
Questio
nnaire 
(RMDQ
) 
PCL 
cat 
  succ
essf
ul 
mult
ileve
l 
regr
essi
on 
anal
ysis 
3-
step 
met
hod 
differen
ces 
baseline 
p<0.10, 
mediatin
g = 
p<0.05 
n.r.        
AC
CE
PT
ED
 
Sme
ets 
20
06 
APT 
vs 
WL 
70 Roland 
and 
Morris 
Disabilit
y 
Questio
nnaire 
(RMDQ
) 
without 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes  Beta -
2.4
15 
-
2.5
3 
-
2.3
0 
 
Sme
ets 
20
06 
CB
T vs 
WL 
70 Roland 
and 
Morris 
Disabilit
y 
Questio
nnaire 
(RMDQ
) 
without 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes  Beta -
3.1
4 
-
3.2
6 
-
3.0
2 
 
Sme
ets 
20
06 
CT 
vs 
WL 
70 Roland 
and 
Morris 
Disabilit
y 
Questio
nnaire 
(RMDQ
) 
without 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes  Beta -
2.5
24 
-
2.6
4 
-
2.4
1 
 
Sme
ets 
20
06 
APT 
vs 
WL 
70 Roland 
and 
Morris 
Disabilit
y 
Questio
nnaire 
(RMDQ
PCL 
cat 
(17-
85) 
no yes, 
mult
ileve
l 
regr
essi
on 
n.r. Beta -
1.2
84 
-
1.3
9 
-
1.1
8 
 
AC
CE
PT
ED
 
) with 
catastro
phizing 
Sme
ets 
20
06 
CB
T vs 
WL 
70 Roland 
and 
Morris 
Disabilit
y 
Questio
nnaire 
(RMDQ
) with 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes, 
mult
ileve
l 
regr
essi
on 
n.r. Beta -
2.2
17 
-
2.3
2 
-
2.1
1 
 
Sme
ets 
20
06 
CT 
vs 
WL 
70 Roland 
and 
Morris 
Disabilit
y 
Questio
nnaire 
(RMDQ
) with 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes, 
mult
ileve
l 
regr
essi
on 
n.r. Beta -
1.6
36 
-
1.7
4 
-
1.5
3 
 
Sme
ets 
20
06 
APT 
vs 
WL 
70 Current 
pain 
(VAS) 
without 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes  Beta -
9.2
82 
-
9.8
4 
-
8.7
2 
 
Sme
ets 
20
06 
CB
T vs 
WL 
70 Current 
pain 
(VAS) 
without 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes  Beta -
15.
826 
-
16.
39 
-
15.
27 
 
Sme
ets 
20
06 
CT 
vs 
WL 
70 Current 
pain 
(VAS) 
without 
PCL 
cat 
(17-
85) 
no yes  Beta -
8.6
85 
-
9.2
4 
-
8.1
3 
 
AC
CE
PT
ED
 
catastro
phizing 
Sme
ets 
20
06 
APT 
vs 
WL 
70 Current 
pain 
(VAS) 
with 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes, 
mult
ileve
l 
regr
essi
on 
n.r. Beta -
4.7
03 
-
5.2
3 
-
4.1
8 
 
Sme
ets 
20
06 
CB
T vs 
WL 
70 Current 
pain 
(VAS) 
with 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes, 
mult
ileve
l 
regr
essi
on 
n.r. Beta -
12.
165 
-
12.
69 
-
11.
64 
 
Sme
ets 
20
06 
CT 
vs 
WL 
70 Current 
pain 
(VAS) 
with 
catastro
phizing 
PCL 
cat 
(17-
85) 
no yes, 
mult
ileve
l 
regr
essi
on 
n.r. Beta -
5.1
24 
-
5.6
4 
-
4.6
1 
  
Spin
-
hov
en 
20
04 
all 360 McGill 
Pain 
Questio
nnaire 
(MPQ), 
pain 
rating 
index 
d_P
CC
L 
cat 
no Hira
rchi-
cal 
regr
essi
on, 
resid
ualiz
ed 
gain 
scor
e 
zero-
order 
correlati
on 
Beta 0.2 0.0
0 
0.4
0 
<0.
05 
Hill 20
08 
all 360 Higher 
than 
median 
value 
RMQ 
(≥3) at 
12 
CS
Q 
cat 
no yes p<0.05 OR 1.7
7 
1.1
3 
2.7
5 
  
AC
CE
PT
ED
 
months 
Han
cock 
20
09 
NS
AID 
vs 
Plac
ebo 
84 Number 
of days 
to 
recovery 
(1 day 
without 
pain = 
recovery
) 
PRS
S 
cat 
(0-
5) 
no yes p<0.25 HR 1.0
95 
0.8
0 
1.4
9 
0.5
67 
Geo
rge 
20
08 
all 180 change 
at 6 
months 
in NRS 
(Numeri
cal 
Rating 
Scale) 
d_P
CS 
(0-
52) 
no yes  Beta 0.3
8 
0.0
9 
0.6
7 
<0.
01 
Ben
eciu
k 
20
12 
PT 
+ 
CB
T vs 
PT 
only 
180 Disabilit
y (ODI) 
PCS 
(0-
52) 
cat 
+ 
FA
B-P 
(<1
4) 
low 
yes, 
Disc
rimi
nant 
Fun
ctio
n 
anal
ysis, 
Clus
ter 
Anal
ysis 
N/A Mea
n 
-4.7 -
17.
24 
7.8
4 
 
Ben
eciu
k 
20
12 
PT 
+ 
CB
T vs 
PT 
only 
180 Disabilit
y (ODI) 
PCS 
(0-
52) 
FA
B-P 
(≥1
4) 
high 
yes, 
Disc
rimi
nant 
Fun
ctio
n 
anal
ysis, 
N/A Mea
n 
3.6 -
14.
16 
21.
36 
 
AC
CE
PT
ED
 
Clus
ter 
Anal
ysis 
Ben
eciu
k 
20
12 
PT 
+ 
CB
T vs 
PT 
only 
180 Disabilit
y (ODI) 
PCS 
(0-
52) 
cat 
+ 
FA
B-P 
(≥1
4) 
high 
yes, 
Disc
rimi
nant 
Fun
ctio
n 
anal
ysis, 
Clus
ter 
Anal
ysis 
N/A Mea
n 
-
16.
9 
-
38.
04 
4.2
4 
 
Ben
eciu
k 
20
12 
PT 
+ 
CB
T vs 
PT 
only 
180 Pain 
Intensity 
(NRS) 
PCS 
(0-
52) 
cat 
+ 
FA
B-P 
(<1
4) 
low 
yes, 
Disc
rimi
nant 
Fun
ctio
n 
anal
ysis, 
Clus
ter 
Anal
ysis 
N/A Mea
n 
0.1 -
2.1
7 
2.3
7 
 
Ben
eciu
k 
20
12 
PT 
+ 
CB
T vs 
PT 
only 
180 Pain 
Intensity 
(NRS) 
PCS 
(0-
52) 
FA
B-P 
(>=
14) 
high 
yes, 
Disc
rimi
nant 
Fun
ctio
n 
anal
ysis, 
Clus
ter 
Anal
ysis 
N/A Mea
n 
1 1.9
1 
3.9
1 
 
AC
CE
PT
ED
 
Ben
eciu
k 
20
12 
PT 
+ 
CB
T vs 
PT 
only 
180 Pain 
Intensity 
(NRS) 
PCS 
(0-
52) 
cat 
+ 
FA
B-P 
(≥1
4) 
high 
yes, 
Disc
rimi
nant 
Fun
ctio
n 
anal
ysis, 
Clus
ter 
Anal
ysis 
N/A Mea
n 
-1.3 -
4.0
9 
1.4
9 
  
 
ms, median split 
 
